Dr. Panos Zanos, head of the Zanos Lab at the University of Cyprus, recently published an article in the Cyprus press, highlighting the therapeutic potential of psychedelics for treating psychiatric disorders. The article explores how substances like psilocybin, MDMA (ecstasy), and ketamine are emerging as innovative treatments for conditions such as depression and PTSD, particularly […]

Read More »

We’re excited to announce that Dr. Andrea Georgiou, head of the Genetics Epidemiology Unit within the Zanos lab was invited to give a talk on her research on biomarkers associated with smoking addiction at KES College in Cyprus. The presentation focused on investigating biological indicators related to smoking dependence in the Cypriot population. Dr. Georgiou brings […]

Read More »

We are pleased to announce that Dr. Zanos was recently invited to appear on the Cyprus Broadcasting Corporation (RIK) to discuss our laboratory’s groundbreaking clinical trial investigating ketamine as a treatment for opioid use disorder (OUD). This pioneering study—the first of its kind in Cyprus—is being conducted at the “GEFYRA” (BRIDGE) Substitute Substance Unit in […]

Read More »

We’re excited to announce that our laboratory is leading a special issue in Microorganisms journal focusing on the intersection of climate change and the human microbiome. Dr. Zanos and Dr. Onisiforou are serving as Guest Editors for this initiative. Our special issue aims to explore how environmental changes affect human-associated microbial communities and their subsequent […]

Read More »

We are excited to welcome Dr. Polymnia Louka to the Translational Neuropharmacology Lab as an ONISILOS Marie Skłodowska-Curie Fellow. Her research focuses on the effects of ketamine’s enantiomers and active metabolites on depression-induced bone impairment, aiming to uncover novel therapeutic interventions at the intersection of neuropharmacology, bone biology, and imaging. Dr. Louka has a diverse […]

Read More »

We are delighted to announce that our recent publication on microbial influences in Alzheimer’s disease has been selected for the cover story for Volume 13, Issue 1 (January 2025) of Microorganisms journal. This recognition by the journal highlights the significance and timeliness of our research in challenging traditional paradigms of Alzheimer’s Disease treatment. The cover […]

Read More »

Dr. Panos Zanos coordinated a public lecture on stress and mental health on January 23rd at the Salaminio Free/Open University of Famagusta. The event featured presentations by Dr. Maria Tsiarli, Ph.D. in Developmental Neurobiology, on “Stress and Nervous System Health,” and Professor Georgia Panayiotou, Dean of the Graduate School at the University of Cyprus, on […]

Read More »

We are excited to announce that Dr. Andria Michael, a postdoctoral fellow in the Zanos Lab, has been awarded the highly competitive YUFE4Postdocs Fellowship, co-funded by the European Union’s Marie Skłodowska-Curie Actions (MSCA) program. This fellowship provides Dr. Michael with a 26-month research position at the University of Cyprus, offering exceptional training opportunities and a […]

Read More »

For decades, Alzheimer’s disease (AD) research has been dominated by the amyloid cascade hypothesis, which positions amyloid-beta (Aβ) accumulation as the primary driver of the disease. However, the consistent failure of Aβ-targeted therapies to demonstrate efficacy, coupled with significant safety concerns, has underscored the critical need to rethink our approach to AD treatment. In our […]

Read More »

We are delighted to announce that the Zanos Laboratory has secured €600,000 in research funding by the Research and Innovation Foundation, to support several innovative research programs in neuroscience and mental health. This funding will enable our laboratory to pursue multiple distinct lines of investigation that address important questions in mental health research. In collaboration […]

Read More »